Rehmann Capital Advisory Group

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1633037 LANSING, MI

Position in JSPR

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$6,441

-$6,961 QoQ

Shares Held

15,300

0.0% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 44 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $2,257,367 across 4 Biotechnology names. JSPR ranks #4 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,812	$1,129,854
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,846	$916,963
3	ARGX	Argenx SE	220	$204,109
4	JSPR	Jasper Therapeutics, Inc. This page	15,300	$6,441

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,441	15,300	0.0%	Shares	Sole	2026-08-20
2026-03-31	$13,402	15,300	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.